pirtobrutinib
eli lilly
['pirto', 'pirtobrutinib', 'oval,(-approval)', 'congrat', 'cll']
very promising efficacy and safety data on 3rd generation, non-covalent btk inhibitor pirtobrutinib in heavily pretreated cll pts, including those progressing on covalent btk inhibitors with btk mutations. congrats and all investigators. #cll 
Hematologist at https://t.co/5Cv9rH6CW0; CLL expert. Professor at https://t.co/iQLiqw0Vhp. Evidence-based medicine. Trumpet / chess / golf player. Tweets are solely my personal views.